{"id":213700,"name":"AMGEN","slug":"amgen","state":"CA","country":"United States of America","description":"Biotechnology.","totalSpending":920000,"filings":17,"yearlySpending":[{"year":2022,"income":200000},{"year":2023,"income":240000},{"year":2024,"income":240000},{"year":2025,"income":240000}],"issues":[{"code":"TAX","display":"Taxation/Internal Revenue Code"},{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"GOV","display":"Government Issues"},{"code":"BUD","display":"Budget/Appropriations"},{"code":"CPT","display":"Copyright/Patent/Trademark"}],"firms":["THE NICKLES GROUP, LLC"],"lobbyists":["RACHEL JONES HENSLER","MARY SAVARY TAYLOR","GREG D'ANGELO","BRETT BAKER","JEFF CHOUDHRY"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Centers For Medicare and Medicaid Services (CMS)","Executive Office of the President (EOP)","Health & Human Services, Dept of (HHS)","Office of Management & Budget (OMB)"],"sampleDescriptions":["Prescription drug reimbursement. General tax issues.","Prescription drug reimbursement. General tax issues.","Prescription drug reimbursement. General tax issues.","H.R. 5376, The Build Better Back Act and issues regarding drug pricing. Issues regarding ESRD payments. H.R. 3517 / S. 1943, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of","Monitored S. 3799, PREVENT Pandemics Act. Monitored issues related to FDA user fee agreements. Issues regarding timely access to medications."]}